Personalized Cannabidiol Delivery and Adaptive Emulsification

A next-generation cannabidiol delivery system that leverages adaptive surfactant ratios, real-time monitoring, and bioresponsive polymers to optimize therapeutic efficacy and individualize treatment.

The original self-emulsifying cannabidiol formulations patent has limitations in terms of generic surfactant ratios and lack of personalized delivery. This new concept addresses these limitations by introducing adaptive surfactant ratios, real-time monitoring, and bioresponsive polymers to create a more effective and personalized cannabidiol delivery system.

The inventive concept comprises a system for personalized cannabidiol delivery, featuring a self-emulsifying composition with adaptive surfactant ratios tailored to an individual's gastrointestinal profile. This is achieved through a wearable device that tracks changes in skin impedance correlated with emulsion globule size, enabling real-time monitoring of cannabidiol absorption. Additionally, the composition includes a bioresponsive polymer that selectively releases cannabidiol in response to specific gut microbiome markers. The system also features a modular oral dosage form with varying surfactant ratios, allowing for dynamic adjustment of emulsion properties in response to changing physiological conditions. Furthermore, the system integrates artificial intelligence-driven dosing recommendations with a self-emulsifying composition optimized for personalized therapeutic efficacy.

The new claims introduce a paradigm shift in cannabidiol delivery by incorporating adaptive surfactant ratios, real-time monitoring, and bioresponsive polymers, which are not present in the original patent. These novel features enable personalized treatment and optimized therapeutic efficacy, making the original inventive concept obsolete.

Alternative embodiments may include using different types of bioresponsive polymers, varying the modular oral dosage form design, or incorporating additional sensors for real-time monitoring. Variations may also include adapting the system for different routes of administration, such as topical or transdermal delivery.

The personalized cannabidiol delivery system has significant commercial potential in the pharmaceutical and nutraceutical industries, particularly in the treatment of chronic diseases and conditions where individualized treatment is crucial. The system's adaptability and real-time monitoring capabilities also make it an attractive solution for precision medicine and personalized healthcare.